Holen Sie sich die Stockscreener-App
12.48
1.96%
-0.25
Handel nachbörslich:
12.46
-0.02
-0.16%
CorMedix Inc Aktie (CRMD) Neueste Nachrichten
MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026? - Finviz
Ocugen Stock Surges 75% Year to Date: What's in Store for 2026? - Finviz
Can CorMedix's Melinta Acquisition Aid Growth Beyond DefenCath? - Yahoo Finance
Responsive Playbooks and the CRMD Inflection - Stock Traders Daily
Meme Stocks: Is Adyen NV 1N8 stock attractive post correctionEarnings Recap Report & Safe Capital Allocation Plans - moha.gov.vn
CorMedix (CRMD): Assessing Valuation After a Strong Multi‑Year Share Price Run - Yahoo Finance
Why CorMedix could be the biopharma name to watch early in 2026 - MSN
CorMedix Builds a Real Revenue Story as DefenCath Adoption Accelerates - Investing.com
CorMedix Clears Key Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Why CorMedix Could be the Biopharma Name to Watch Early in 2026 - sharewise.com
CorMedix Inc.'s (NASDAQ:CRMD) 28% Jump Shows Its Popularity With Investors - simplywall.st
CorMedix CEO Todisco sells $360,000 in CRMD stock - Investing.com India
CorMedix CEO Todisco sells $360,000 in CRMD stock By Investing.com - Investing.com Nigeria
CRMD SEC FilingsCormedix 10-K, 10-Q, 8-K Forms - Stock Titan
How CorMedix Inc. stock compares to market leadersWeekly Profit Summary & Fast Moving Stock Trade Plans - Улправда
Can CorMedix Inc. stock surprise with earnings upside2025 Growth vs Value & Weekly Breakout Watchlists - moha.gov.vn
Bear Alert: How CorMedix Inc. stock compares to market leadersMarket Growth Summary & Free Technical Confirmation Trade Alerts - Улправда
How rising interest rates impact CorMedix Inc. stockGDP Growth & Real-Time Sentiment Analysis - Улправда
How CorMedix Inc. stock reacts to global recession fears2025 Winners & Losers & Short-Term Swing Trade Alerts - Улправда
CEO Todisco Sells 30,000 ($360K) Of CorMedix Inc [CRMD] - TradingView — Track All Markets
Income Plays: Can CorMedix Inc. stock surprise with earnings upsideWeekly Trade Review & Accurate Intraday Trading Signals - Улправда
Will CorMedix Inc. (19KA) stock benefit from infrastructure billJuly 2025 Pullbacks & Low Risk Investment Opportunities - Улправда
Is It Too Late to Consider CorMedix After DefenCath Progress and Strong Price Gains? - Yahoo Finance
Will CorMedix Inc. (19KA) stock gain from lower interest rates2025 Historical Comparison & Fast Exit/Entry Strategy Plans - DonanımHaber
Sentiment Recap: Will CorMedix Inc. (19KA) stock gain from lower interest ratesJuly 2025 Retail & Safe Entry Point Identification - DonanımHaber
Is CorMedix Inc. stock a top pick in earnings season2025 Market Outlook & Smart Investment Allocation Insights - DonanımHaber
Will CorMedix Inc. (19KA) stock hit analyst forecastsWeekly Trade Review & Weekly High Potential Stock Alerts - DonanımHaber
Can CorMedix Inc. (19KA) stock surprise with quarterly resultsQuarterly Market Summary & AI Powered Buy/Sell Recommendations - ulpravda.ru
Breakout Move: How sustainable is CorMedix Inc. stock dividend payoutWeekly Stock Analysis & Risk Controlled Stock Alerts - Улправда
CorMedix announces interim results for DefenCath - TipRanks
Why Is CorMedix Stock Rising Today? - Asianet Newsable
CorMedix Says Interim DefenCath Study Data Show Fewer Infections - marketscreener.com
Cormedix reports positive data from real world study of Defencath - marketscreener.com
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath - The Manila Times
CRMD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Buy? - Yahoo Finance
(CRMD) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance - MSN
CRMD up more than 40% YTD: Time to buy, sell or hold the stock? - MSN
Cormedix Director Makes a Significant Stock Sale! - TipRanks
CorMedix Q3 2025 Earnings Preview - MSN
CRMD Up More Than 40% YTD: Time to Buy, Sell or Hold the Stock? - sharewise.com
CorMedix director Dillione sells $408,000 in stock By Investing.com - Investing.com South Africa
CorMedix director Dillione sells $408,000 in stock - Investing.com
Steven Lefkowitz Implements A Sell Strategy: Offloads $475K In Cormedix Stock - Benzinga
CorMedix Inc. Stock (CRMD) Opinions on Insider Selling and Growth Metrics - Quiver Quantitative
CorMedix Insider Sold Shares Worth $408,000, According to a Recent SEC Filing - marketscreener.com
CorMedix Director Janet Dillione Sells 34,000 Shares - TradingView — Track All Markets
Dir Dillione Sells 34,000 ($408K) Of CorMedix Inc [CRMD] - TradingView — Track All Markets
Lefkowitz Steven W, director at CorMedix, sells $475k in CRMD stock By Investing.com - Investing.com South Africa
Lefkowitz Steven W, director at CorMedix, sells $475k in CRMD stock - Investing.com Nigeria
0.23%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):